Considerations for Dose Selection and Clinical Pharmacokinetics/Pharmacodynamics for the Development of Antibacterial Agents

In June 2017, The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, organized a workshop entitled “Pharmacokinetics-Pharmacodynamics (PK/PD) for Development of Therapeutics against Bacterial Pathogens” to discuss details and critical parameters of vari...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Rizk, M. L., Bhavnani, S. M., Drusano, G., Dane, A., Eakin, A. E., Guina, T., Jang, S. H., Tomayko, J. F., Wang, J., Zhuang, L., Lodise, T. P.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2019
Matèries:
Minireview
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496063/
https://ncbi.nlm.nih.gov/pubmed/30833427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02309-18
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars